Global pain management drugs market was valued US$ 35.2 Bn in 2017 and is expected to reach US$ 52.6 Bn by 2026, at a CAGR of 5.15% during a forecast period.
Global Pain Management Drugs MarketPain management is the medical field used for treating all types of pain containing musculoskeletal, spinal and neuropathic pain disorders. It is used to improve the quality of life of individuals suffering from pain.
Growth in geriatric population is the major factor that drives the growth of the global pain management market due to the elderly people are more likely to suffer from joint pain as well as chronic disorders such as heart disease, stroke, diabetes, and cancer.
DOWNLOAD FREE SAMPLE REPORT: https://www.maximizemarketresearch.com/market-report/global-pain-management-drugs-market/23895/#requestforsample
The rise in alertness regarding the side-effects of pain medication, and growing the occurrence & prevalence of chronic diseases is also boosting the growth of the market. Availability of alternative therapies and a rise in drug mistreatment are obstructing the growth of the pain management drugs market.
Prescription medicine is leading the market, owing to the drugs are only available with a valid prescription from a doctor. Prescription drugs must pass through many clinical trial phases, approval by the food and drug administration (FDA), and observed for safety & side effects even after the drug is on the market. OTC drugs are available without consulting with a prescriber or pharmacist, though the patient is to be aware of these drugs still carry a risk. OTC drugs are monitored by the food and drug administration, but it is not as stringent as the process prescription drugs must go through.
Migraine is very common and it is a type of headache-related disorder with sensitivity towards odor, light or acoustics. Migraines can be treated with abortive and preventive. Abortive medications are work quickly and especially useful for people who have nausea & vomiting related to their migraine. Abortive medications can be taken by self-injection, mouth, and skin patch.
Fibromyalgia is a common type of chronic pain where the patient suffers from musculoskeletal pain along with memory, fatigue, sleep and mood issues.
Asia-Pacific is estimated to be the fastest-growing region for the pain management drugs market owing to the presence of a larger patient pool and the growth in healthcare expenditure in this region. Japan is the largest contributor and China & India are the fastest growing countries towards the Asia-Pacific region in the global pain management drugs markets.
The major market players in the global pain management drugs market are Pfizer, Inc., Purdue Pharma L.P., Eli Lilly And Company, GlaxoSmithKline, and Johnson & Johnson.
The report covers a comprehensive study of major market drivers, restrains, opportunities, challenges, PESTEL, Porters, SWOT, and technological forecasting in the market.
Do Inquiry Before Purchasing Report Here: https://www.maximizemarketresearch.com/market-report/global-pain-management-drugs-market/23895/#inquiry
The Scope of Global Pain Management Drugs Market:
Global Pain Management Drugs Market, by Category:
• Prescription-Based Drugs
• Over-The-Counter (OTC) Drugs
Global Pain Management Drugs Market, by Therapeutic Indications:
• Post-Operative Pain
• Low-Back Pain
• Rheumatoid Arthritis Pain
• Osteoarthritis Pain
• Cancer Pain
• Migraine
• Neuropathic Pain
• Fibromyalgia
• Others
Global Pain Management Drugs Market, by Brands:
• Maxalt
• Zomig
• Qutenza
• Lidoderm
• Savella
• Imitrex
• Voltaren Gel
• Celebrex
• Cymbalta
• Others
Global Pain Management Drugs Market, by Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa
Key Player Operating In the Global Pain Management Drugs Market:
• Pfizer, Inc.
• Purdue Pharma L.P.
• Eli Lilly And Company
• GlaxoSmithKline
• Johnson & Johnson
• Endo Pharmaceuticals
• Allergen Inc.
• Bayer AG
• Bristol-Myers Squibb
• Valeant Pharmaceuticals International Inc.
• Boehringer Ingelheim
• Sorrento Therapeutics
• WEX Pharmaceuticals
• Zynerba Pharmaceuticals
• GSK
• Grunenthal
• AstraZeneca
• Depomed
• Teva
• Allergan
MAJOR TOC OF THE REPORT
Chapter One: Pain Management Drugs Market Overview
Chapter Two: Manufacturers Profiles
Chapter Three: Global Pain Management Drugs Market Competition, by Players
Chapter Four: Global Pain Management Drugs Market Size by Regions
Chapter Five: North America Pain Management Drugs Revenue by Countries
Chapter Six: Europe Pain Management Drugs Revenue by Countries
Chapter Seven: Asia-Pacific Pain Management Drugs Revenue by Countries
Chapter Eight: South America Pain Management Drugs Revenue by Countries
Chapter Nine: Middle East and Africa Revenue Pain Management Drugs by Countries
Chapter Ten: Global Pain Management Drugs Market Segment by Type
Chapter Eleven: Global Pain Management Drugs Market Segment by Application
Chapter Twelve: Global Pain Management Drugs Market Size Forecast (2019-2026)
Browse Table of Contents with Facts and Figures of Pain Management Drugs Market Report at: https://www.maximizemarketresearch.com/market-report/global-pain-management-drugs-market/23895/
About Us:
Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
Contact info:
Name: Lumawant Godage
Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.
Email: sales@maximizemarketresearch.com
Contact:+919607065656/ +919607195908
Website: www.maximizemarketresearch.com